You are here

Molecular Templates to Present at the Cowen and Company 38th Annual Health Care Conference

AUSTIN, Texas, March 08, 2018 (GLOBE NEWSWIRE) -- Molecular Templates, Inc., (Nasdaq:MTEM) a clinical stage biopharmaceutical company focused on the discovery and development of Engineered Toxin Bodies (ETBs), a new class of targeted biologic therapies that possess unique mechanisms of action in oncology, today announced that its management will provide a corporate overview at the Cowen and Company 38th Annual Health Care Conference, taking place March 12-14 at the Boston Marriott Copley Place in Boston, MA.

Presentation Details 
Date:Tuesday, March 13
Time:11:20am Eastern Time
Location:The Boston Marriott Copley Place

About Molecular Templates  

Molecular Templates is focused on the discovery, development and commercialization of next-generation immunotoxins called Engineered Toxin Bodies (ETBs) for the treatment of cancers and other serious diseases. For additional information, please visit Molecular Templates’ website at

Investor Contact:
Andrew McDonald, Ph.D.

Adam Cutler
Chief Financial Officer

Thursday, March 8, 2018 - 08:00